Published in J Urol on April 16, 2011
Optimizing Psychosocial Treatment of Interstitial Cystitis/Bladder Pain Syndrome | NCT04275297
The overlap and distinction of self-reported symptoms between interstitial cystitis/bladder pain syndrome and overactive bladder: a questionnaire based analysis. J Urol (2014) 1.54
Expression and function of transforming growth factor-β isoforms and cognate receptors in the rat urinary bladder following cyclophosphamide-induced cystitis. Am J Physiol Renal Physiol (2013) 1.53
Botulinum toxin for conditions of the female pelvis. Int Urogynecol J (2013) 1.39
Metabolomics insights into pathophysiological mechanisms of interstitial cystitis. Int Neurourol J (2014) 1.12
Pentosan polysulfate: a novel therapy for the mucopolysaccharidoses. PLoS One (2013) 1.06
Polysymptomatic, polysyndromic presentation of patients with urological chronic pelvic pain syndrome. J Urol (2012) 1.04
The role(s) of cytokines/chemokines in urinary bladder inflammation and dysfunction. Biomed Res Int (2014) 0.95
Antiproliferative factor signaling and interstitial cystitis/painful bladder syndrome. Int Neurourol J (2011) 0.94
Intravesical treatments of bladder pain syndrome/interstitial cystitis. Nat Rev Urol (2012) 0.92
Changes in symptoms during urologic chronic pelvic pain syndrome symptom flares: findings from one site of the MAPP Research Network. Neurourol Urodyn (2013) 0.92
Toll-like receptor 4 and comorbid pain in Interstitial Cystitis/Bladder Pain Syndrome: a multidisciplinary approach to the study of chronic pelvic pain research network study. Brain Behav Immun (2015) 0.91
An endogenous pain control system is altered in subjects with interstitial cystitis. J Urol (2013) 0.91
Novel Treatment of Chronic Bladder Pain Syndrome and Other Pelvic Pain Disorders by OnabotulinumtoxinA Injection. Toxins (Basel) (2015) 0.91
Neurotrophins as regulators of urinary bladder function. Nat Rev Urol (2012) 0.90
'Omics' approaches to understanding interstitial cystitis/painful bladder syndrome/bladder pain syndrome. Int Neurourol J (2012) 0.90
Interstitial cystitis/bladder pain syndrome: diagnosis and management. Int Urogynecol J (2013) 0.89
Urinary metabolite profiling combined with computational analysis predicts interstitial cystitis-associated candidate biomarkers. J Proteome Res (2014) 0.87
Neuromodulation for overactive bladder. Nat Rev Urol (2013) 0.87
Correlation between psychological stress levels and the severity of overactive bladder symptoms. BMC Urol (2015) 0.86
Differential effects of intravesical resiniferatoxin on excitability of bladder spinal neurons upon colon-bladder cross-sensitization. Brain Res (2012) 0.85
Bladder afferent hyperexcitability in bladder pain syndrome/interstitial cystitis. Int J Urol (2014) 0.85
Segmental hyperalgesia to mechanical stimulus in interstitial cystitis/bladder pain syndrome: evidence of central sensitization. J Urol (2013) 0.85
Measuring the success of combined intravesical dimethyl sulfoxide and triamcinolone for treatment of bladder pain syndrome/interstitial cystitis. Int Urogynecol J (2012) 0.84
Dose responsive effects of subcutaneous pentosan polysulfate injection in mucopolysaccharidosis type VI rats and comparison to oral treatment. PLoS One (2014) 0.84
Altered detrusor gap junction communications induce storage symptoms in bladder inflammation: a mouse cyclophosphamide-induced model of cystitis. PLoS One (2014) 0.84
Intravesical hyaluronic acid and alkalinized lidocaine for the treatment of severe painful bladder syndrome/interstitial cystitis. Int Urogynecol J (2012) 0.83
Pathomechanism of Interstitial Cystitis/Bladder Pain Syndrome and Mapping the Heterogeneity of Disease. Int Neurourol J (2016) 0.83
Seminal plasma as a source of prostate cancer peptide biomarker candidates for detection of indolent and advanced disease. PLoS One (2013) 0.82
Efficacy of intravesical chondroitin sulphate in treatment of interstitial cystitis/bladder pain syndrome (IC/BPS): Individual patient data (IPD) meta-analytical approach. Can Urol Assoc J (2013) 0.82
Combined intravesical sodium hyaluronate/chondroitin sulfate therapy for interstitial cystitis/bladder pain syndrome: a prospective study. Ther Adv Urol (2013) 0.82
Treating interstitial cystitis/bladder pain syndrome as a chronic disease. Rev Urol (2014) 0.81
A healthy bladder: a consensus statement. Int J Clin Pract (2011) 0.81
Effects of combination treatment of intravesical resiniferatoxin instillation and hydrodistention in patients with refractory painful bladder syndrome/interstitial cystitis: a pilot study. Int Neurourol J (2012) 0.81
Animal Models of Urologic Chronic Pelvic Pain Syndromes: Findings From the Multidisciplinary Approach to the Study of Chronic Pelvic Pain Research Network. Urology (2015) 0.80
Urological chronic pelvic pain syndrome flares and their impact: qualitative analysis in the MAPP network. Int Urogynecol J (2015) 0.80
Long-Term Efficacy and Safety of Repeated Intravescial OnabotulinumtoxinA Injections Plus Hydrodistention in the Treatment of Interstitial Cystitis/Bladder Pain Syndrome. Toxins (Basel) (2015) 0.80
Interstitial cystitis/bladder pain syndrome and glycosaminoglycans replacement therapy. Transl Androl Urol (2015) 0.78
Interstitial cystitis/painful bladder syndrome: the influence of modern diagnostic criteria on epidemiology and on Internet search activity by the public. Transl Androl Urol (2015) 0.78
Increased expression of TNF ligand-related molecule 1A and death receptor 3 in bladder tissues of patients with painful bladder syndrome/interstitial cystitis. Exp Ther Med (2012) 0.78
Early in life bladder inflammation alters opioid peptide content in the spinal cord and bladder of adult female rats. J Urol (2012) 0.78
Mindfulness-based stress reduction as a novel treatment for interstitial cystitis/bladder pain syndrome: a randomized controlled trial. Int Urogynecol J (2016) 0.78
Intravesical chondroitin sulphate for interstitial cystitis/painful bladder syndrome. Ulster Med J (2015) 0.78
Elimination of Hunner's Ulcers by Fulguration in Patients With Interstitial Cystitis: Is It Effective and Long Lasting? Korean J Urol (2013) 0.78
Bladder pain syndrome: validation of simple tests for diagnosis in women with chronic pelvic pain: BRaVADO study protocol. Reprod Health (2013) 0.78
Intravesical liposome drug delivery and IC/BPS. Transl Androl Urol (2015) 0.77
A rat long-lasting cystitis model induced by intravesical injection of hydrogen peroxide. Physiol Rep (2017) 0.77
Managing chronic bladder diseases with the administration of exogenous glycosaminoglycans: an update on the evidence. Ther Adv Urol (2015) 0.77
A synthetic form of frizzled 8-associated antiproliferative factor enhances p53 stability through USP2a and MDM2. PLoS One (2012) 0.77
Intravesical Botulinum Toxin A Injections for Bladder Pain Syndrome/Interstitial Cystitis: A Systematic Review and Meta-Analysis of Controlled Studies. Med Sci Monit (2016) 0.76
Pretreatment features to influence effectiveness of intravesical hyaluronic Acid instillation in refractory interstitial cystitis/painful bladder syndrome. Int Neurourol J (2014) 0.76
Noninvasive multianalyte diagnostic assay for monitoring bladder cancer recurrence. Res Rep Urol (2012) 0.76
Treatment of interstitial cystitis/painful bladder syndrome as a neuropathic pain condition. Indian J Urol (2014) 0.76
A prospective randomized controlled multicentre trial comparing intravesical DMSO and chondroïtin sulphate 2% for painful bladder syndrome/interstitial cystitis. Int Braz J Urol (2017) 0.75
Recommendations to the primary care practitioners and the patients for managing pelvic pain, especially in painful bladder syndrome for early and better prognosis. J Exerc Rehabil (2015) 0.75
Effects of interstitial cystitis on the acoustic startle reflex in cats. Am J Vet Res (2013) 0.75
Botulinum Toxin A for Bladder Pain Syndrome/Interstitial Cystitis. Toxins (Basel) (2016) 0.75
Amitriptyline: interstitial cystitis (painful bladder syndrome). Hosp Pharm (2014) 0.75
The Chinese approach to complementary and alternative medicine treatment for interstitial cystitis/bladder pain syndrome. Transl Androl Urol (2015) 0.75
Interstitial Cystitis-Associated Urinary Metabolites Identified by Mass-Spectrometry Based Metabolomics Analysis. Sci Rep (2016) 0.75
Pulsed radiofrequency treatment of the superior hypogastric plexus in an interstitial cystitis patient with chronic pain and symptoms refractory to oral and intravesical medications and bladder hydrodistension: A case report. Medicine (Baltimore) (2016) 0.75
TGF-β/MAPK signaling mediates the effects of bone marrow mesenchymal stem cells on urinary control and interstitial cystitis after urinary bladder transplantation. Am J Transl Res (2017) 0.75
Clinical presentation and treatment of bladder pain syndrome/interstitial cystitis (BPS/IC) in India. Transl Androl Urol (2015) 0.75
The combination therapy of prednisolone and tacrolimus for severe painful bladder syndrome/interstitial cystitis. Can Urol Assoc J (2012) 0.75
Individual receptor profiling as a novel tool to support diagnosis of bladder pain syndrome/interstitial cystitis (BPS/IC). World J Urol (2011) 0.75
Increased urothelial paracellular transport promotes cystitis. Am J Physiol Renal Physiol (2015) 0.75
Depression and catastrophizing predict suicidal ideation in tertiary care patients with interstitial cystitis/bladder pain syndrome. Can Urol Assoc J (2017) 0.75
Complementary and alternative medical therapies for interstitial cystitis: an update from the United States. Transl Androl Urol (2015) 0.75
Transcriptome analysis of bladder biopsy from interstitial cystitis/bladder pain syndrome patients. Genom Data (2014) 0.75
The enigma of men with interstitial cystitis/bladder pain syndrome. Transl Androl Urol (2015) 0.75
Important role of physicians in addressing psychological aspects of interstitial cystitis/bladder pain syndrome (IC/BPS): a qualitative analysis. Int Urogynecol J (2016) 0.75
A multiplexed analysis approach identifies new association of inflammatory proteins in patients with overactive bladder. Am J Physiol Renal Physiol (2016) 0.75
Bladder Distension Increases Blood Flow in Pain Related Brain Structures in Subjects with Interstitial Cystitis. J Urol (2016) 0.75
Current guidelines in the management of interstitial cystitis. Transl Androl Urol (2015) 0.75
Intravesical treatment of painful bladder syndrome: the potential pitfalls of meta-analyses. Int Urogynecol J (2012) 0.75
Intravesical heparin: interstitial cystitis (painful bladder syndrome). Hosp Pharm (2013) 0.75
From bladder to systemic syndrome: concept and treatment evolution of interstitial cystitis. Int J Womens Health (2015) 0.75
Grading of evidence for bladder pain syndrome: a comparative review of study quality assessment methods. Int Urogynecol J (2013) 0.75
Urothelial Tight Junction Barrier Dysfunction Sensitizes Bladder Afferents. eNeuro (2017) 0.75
Effective treatment of ketamine-associated cystitis with botulinum toxin type a injection combined with bladder hydrodistention. J Int Med Res (2017) 0.75
Quality of information on the internet related to bladder pain syndrome: a systematic review of the evidence. Int Urogynecol J (2013) 0.75
Pelvic pain in urogynecology. Part II: treatment options in patients with lower urinary tract symptoms. Int Urogynecol J (2012) 0.75
Guideline for management of the clinical T1 renal mass. J Urol (2009) 8.26
Guideline for the management of clinically localized prostate cancer: 2007 update. J Urol (2007) 6.73
Best practice policy statement on urologic surgery antimicrobial prophylaxis. J Urol (2008) 4.90
American Urological Association guideline on the management of priapism. J Urol (2003) 3.77
Diagnosis and treatment of overactive bladder (non-neurogenic) in adults: AUA/SUFU guideline. J Urol (2012) 2.96
Prevalence of symptoms of bladder pain syndrome/interstitial cystitis among adult females in the United States. J Urol (2011) 2.78
Prospective, randomized, double-blind study of the efficacy and tolerability of the extended-release formulations of oxybutynin and tolterodine for overactive bladder: results of the OPERA trial. Mayo Clin Proc (2003) 2.75
Comparison of culture screening methods for detection of nasal carriage of methicillin-resistant Staphylococcus aureus: a prospective study comparing 32 methods. J Clin Microbiol (2003) 2.70
Adjuvant and salvage radiotherapy after prostatectomy: AUA/ASTRO Guideline. J Urol (2013) 2.59
Symptoms of interstitial cystitis, painful bladder syndrome and similar diseases in women: a systematic review. J Urol (2007) 2.35
Immediate effects of the initial FDA notification on the use of surgical mesh for pelvic organ prolapse surgery in medicare beneficiaries. Neurourol Urodyn (2012) 2.35
Fecal and urinary incontinence in primiparous women. Obstet Gynecol (2006) 2.28
Simple cystectomy: outcomes of a new operative technique. Urology (2011) 2.17
A new classification is needed for pelvic pain syndromes--are existing terminologies of spurious diagnostic authority bad for patients? J Urol (2006) 2.13
Suicidal ideation among patients with bladder pain syndrome/interstitial cystitis. Urology (2012) 2.08
A simple method for teaching about voiding disorders. BJU Int (2006) 2.03
Comparison of an interstitial cystitis/bladder pain syndrome clinical cohort with symptomatic community women from the RAND Interstitial Cystitis Epidemiology study. J Urol (2011) 1.98
Outcomes of vaginal prolapse surgery among female Medicare beneficiaries: the role of apical support. Obstet Gynecol (2013) 1.88
Development, validation and testing of an epidemiological case definition of interstitial cystitis/painful bladder syndrome. J Urol (2010) 1.87
A contemporary assessment of nocturia: definition, epidemiology, pathophysiology, and management--a systematic review and meta-analysis. Eur Urol (2012) 1.81
Robot-assisted versus open sacrocolpopexy: a cost-minimization analysis. J Urol (2011) 1.78
Complications requiring reoperation following vaginal mesh kit procedures for prolapse. Am J Obstet Gynecol (2008) 1.77
A refocus on the bladder as the originator of storage lower urinary tract symptoms: a systematic review of the latest literature. Eur Urol (2009) 1.76
How does the pre-massage and post-massage 2-glass test compare to the Meares-Stamey 4-glass test in men with chronic prostatitis/chronic pelvic pain syndrome? J Urol (2006) 1.68
Rationale and design issues of the Randomized Intervention for Children With Vesicoureteral Reflux (RIVUR) study. Pediatrics (2008) 1.68
Vulvodynia: a state-of-the-art consensus on definitions, diagnosis and management. J Reprod Med (2006) 1.66
Lower urinary tract symptoms revisited: a broader clinical perspective. Eur Urol (2008) 1.62
Quantitative assessment of experimental pain perception: multiple domains of clinical relevance. Pain (2005) 1.60
Numbers and types of nonbladder syndromes as risk factors for interstitial cystitis/painful bladder syndrome. Urology (2011) 1.59
Nocturia Think Tank: focus on nocturnal polyuria: ICI-RS 2011. Neurourol Urodyn (2012) 1.56
Chapter 1: The management of erectile dysfunction: an AUA update. J Urol (2005) 1.55
Epidemiology and healthcare utilization of neurogenic bladder patients in a US claims database. Neurourol Urodyn (2010) 1.55
Bladder Pain Syndrome Committee of the International Consultation on Incontinence. Neurourol Urodyn (2010) 1.55
A randomized controlled trial of intravesical bacillus calmette-guerin for treatment refractory interstitial cystitis. J Urol (2005) 1.54
The New England Research Institutes, Inc. (NERI) Nocturia Advisory Conference 2012: focus on outcomes of therapy. BJU Int (2013) 1.52
The efficacy and safety of combined therapy with α-blockers and anticholinergics for men with benign prostatic hyperplasia: a meta-analysis. J Urol (2013) 1.52
Urodynamic studies in adults: AUA/SUFU guideline. J Urol (2012) 1.51
Depressive disorders and panic attacks in women with bladder pain syndrome/interstitial cystitis: a population-based sample. Gen Hosp Psychiatry (2011) 1.50
Quality of life in women with stress urinary incontinence. Int Urogynecol J Pelvic Floor Dysfunct (2006) 1.49
Prevalence and severity of undiagnosed urinary incontinence in women. Am J Med (2009) 1.48
Histologic comparison of pubovaginal sling graft materials: a comparative study. Urology (2008) 1.48
Antecedent nonbladder syndromes in case-control study of interstitial cystitis/painful bladder syndrome. Urology (2008) 1.46
Overactive bladder: evaluation and management in primary care. Cleve Clin J Med (2005) 1.45
Incontinence-associated dermatitis: consensus statements, evidence-based guidelines for prevention and treatment, and current challenges. J Wound Ostomy Continence Nurs (2012) 1.45
Randomized multicenter feasibility trial of myofascial physical therapy for the treatment of urological chronic pelvic pain syndromes. J Urol (2009) 1.45
Reliability of health-related quality-of-life measures 1 year after surgical procedures for pelvic floor disorders. Am J Obstet Gynecol (2005) 1.44
Mitoxantrone and etoposide with or without intermediate dose cytarabine for the treatment of primary induction failure or relapsed acute myeloid leukemia. Leuk Res (2011) 1.44
A semi-persistent adult ocular dominance plasticity in visual cortex is stabilized by activated CREB. Learn Mem (2004) 1.43
Poverty and human development: a WOC perspective. J Wound Ostomy Continence Nurs (2007) 1.39
A randomized, controlled clinical trial of a novel intravesical pressure attenuation device for the treatment of stress urinary incontinence. J Urol (2013) 1.38
Interstitial cystitis and painful bladder syndrome. J Urol (2007) 1.37
Early results of pubovaginal sling lysis by midline sling incision. Urology (2002) 1.37
Demographic and clinical predictors of treatment failure one year after midurethral sling surgery. Obstet Gynecol (2011) 1.35
Intravesical resiniferatoxin for the treatment of interstitial cystitis: a randomized, double-blind, placebo controlled trial. J Urol (2005) 1.35
Randomized Intervention for Children With Vesicoureteral Reflux (RIVUR): background commentary of RIVUR investigators. Pediatrics (2008) 1.33
AUA guideline on the pharmacologic management of premature ejaculation. J Urol (2004) 1.28
National trends in the usage and success of sacral nerve test stimulation. J Urol (2011) 1.27
Adjuvant and salvage radiation therapy after prostatectomy: American Society for Radiation Oncology/American Urological Association guidelines. Int J Radiat Oncol Biol Phys (2013) 1.25
Erectile function outcome reporting after clinically localized prostate cancer treatment. J Urol (2007) 1.25
Porcine dermis interposition graft for repair of high grade anterior compartment defects with or without concomitant pelvic organ prolapse procedures. J Urol (2004) 1.21
Urogenital pain--time to accept a new approach to phenotyping and, as a consequence, management. Eur Urol (2007) 1.19
Approach to management of iatrogenic foreign bodies of the lower urinary tract following reconstructive pelvic surgery. J Urol (2012) 1.19
Bladder management after spinal cord injury in the United States 1972 to 2005. J Urol (2010) 1.18
Polypropylene mesh tape for stress urinary incontinence: complications of urethral erosion and outlet obstruction. J Urol (2002) 1.18
Effect of amitriptyline on symptoms in treatment naïve patients with interstitial cystitis/painful bladder syndrome. J Urol (2010) 1.17
Effects of nicotine on elevated plus maze and locomotor activity in male and female adolescent and adult rats. Pharmacol Biochem Behav (2004) 1.17
The relationship among symptoms, sleep disturbances and quality of life in patients with interstitial cystitis. J Urol (2009) 1.15
Urgency assessment in the evaluation of overactive bladder (OAB). Neurourol Urodyn (2008) 1.14
Women's sexual pain disorders. J Sex Med (2010) 1.13
Efficacy and safety of oxybutynin chloride topical gel for overactive bladder: a randomized, double-blind, placebo controlled, multicenter study. J Urol (2009) 1.11
Psychosocial variables affect the quality of life of men diagnosed with chronic prostatitis/chronic pelvic pain syndrome. BJU Int (2007) 1.10
Oxybutynin transdermal system improves the quality of life in adults with overactive bladder: a multicentre, community-based, randomized study. BJU Int (2006) 1.08
AUA Best Practice Statement for the prevention of deep vein thrombosis in patients undergoing urologic surgery. J Urol (2009) 1.07
Analgesic effects of intravenous lidocaine and morphine on postamputation pain: a randomized double-blind, active placebo-controlled, crossover trial. Anesthesiology (2002) 1.05
Sexual function is a determinant of poor quality of life for women with treatment refractory interstitial cystitis. J Urol (2007) 1.03
Risk factors for fecal and urinary incontinence after childbirth: the childbirth and pelvic symptoms study. Am J Gastroenterol (2007) 1.03
Comparison of pressure ulcer treatments in long-term care facilities: clinical outcomes and impact on cost. J Wound Ostomy Continence Nurs (2005) 1.03
What is a clinician to do-believe the patient or her urinary diary? J Urol (2006) 1.03
Epidemiology of stress urinary incontinence in women. Curr Urol Rep (2011) 1.02
Patterns and predictors of urodynamics use in the United States. J Urol (2012) 1.02
Enzymatic wound debridement. J Wound Ostomy Continence Nurs (2008) 1.02
Pay for performance: rationale and potential implications for urology. J Urol (2007) 1.01
Transdermal delivery of drugs for urologic applications: basic principles and applications. Urology (2006) 1.01
Nursing interventions to reduce the risk of catheter-associated urinary tract infection. Part 1: Catheter selection. J Wound Ostomy Continence Nurs (2009) 1.00
Redesigning a large-scale clinical trial in response to negative external trial results: the CAMUS study of phytotherapy for benign prostatic hyperplasia. Clin Trials (2009) 0.99
Collagenase for enzymatic debridement: a systematic review. J Wound Ostomy Continence Nurs (2009) 0.99
Correlation between 2 interstitial cystitis symptom instruments. J Urol (2005) 0.98
Obturator foramen dissection for excision of symptomatic transobturator mesh. J Urol (2012) 0.98
Hot tub-associated necrotizing pneumonia due to Pseudomonas aeruginosa. Clin Infect Dis (2003) 0.98
Medical and psychosocial complications associated with method of bladder management after traumatic spinal cord injury. Arch Phys Med Rehabil (2011) 0.98
Evidence-based criteria for pain of interstitial cystitis/painful bladder syndrome in women. Urology (2008) 0.98
Role of nicotinic and estrogen signaling during experimental acute and chronic bladder inflammation. Am J Pathol (2007) 0.98
Urethral injections for female stress incontinence. BJU Int (2006) 0.97
Modeling clinically heterogeneous presenilin mutations with transgenic Drosophila. Curr Biol (2006) 0.97